TB-500 dose guide

TB-500 dosage

A fragment of thymosin beta-4, a protein your body uses for cell repair. TB-500 copies the part of the protein that handles actin, the scaffolding cells use to move, so it helps repair cells reach injured tissue. Commonly reported: stubborn soft-tissue injuries loosening up, with range of motion returning over a few weeks. Its own research is a few animal studies; the human trials tested the whole protein. Often paired with BPC-157.

Dose range

1–2.5 mg (research range). Studied in research — not a recommendation.

How often

2× weekly: 2x/week loading, 1–2mg/week maintenance

A typical run

4–8 weeks. Loading phase 2x/week for 4–6 weeks, then maintenance 1x/week or stop. Common to cycle 6–8 weeks on, time off.

How it’s taken

Vial: SubQ injection, IM injection

Evidence

Emerging: Primarily preclinical / limited human data

Half-life

~0.5–2 hours (measured for the whole protein, thymosin beta-4, given IV to healthy volunteers; TB-500 itself has never been measured in people)

TB-500 on your syringe

With a 10 mg vial and 2 mL of water (5 mg in every mL), on a 0.5 mL (50-unit) U-100 insulin syringe: the low end, 1 mg, is 20 units; and the high end, 2.5 mg, is 50 units. 10 doses in the vial at the low end. All U-100: 100 units to the mL. A U-40 syringe reads differently.

BPC-157: the human data we haveWhat to take alongside each peptideTB-500 in the peptide libraryThe Dose Guide: every peptide

More healing peptides

• BPC-157 200–500 mcg
• GHK-Cu 1–2 mg
• KPV 100–300 mcg
• AOD-9604 250–300 mcg
• Thymosin Alpha-1 1–1.6 mg
• Thymosin Beta-4 2–2.5 mg
• LL-37 100–300 mcg
• Larazotide 0.5–1 mg
• VIP 50 mcg
• ARA-290 1–4 mg
• Cartalax No reference dose
• Ac-SDKP 250–750 mcg

A community reference, not medical advice. Each range is what has been studied or is commonly run, never a dose for you.